These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38421965)
21. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization? Burgmans MC; Too CW; Kao YH; Goh AS; Chow PK; Tan BS; Tay KH; Lo RH Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411 [TBL] [Abstract][Full Text] [Related]
22. 90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy. Bagni O; D'Arienzo M; Chiaramida P; Chiacchiararelli L; Cannas P; D'Agostini A; Cianni R; Salvatori R; Scopinaro F Nucl Med Commun; 2012 Feb; 33(2):198-204. PubMed ID: 22124359 [TBL] [Abstract][Full Text] [Related]
23. An In-House 3D Voxel Dosimetric Tool to Compare Predictive and Post- Treatment Dosimetry in Ferrando O; Bampi R; Foppiano F; Ciarmiello A Curr Radiopharm; 2023 Jun; 16(3):214-221. PubMed ID: 36790008 [TBL] [Abstract][Full Text] [Related]
24. Calculation of lung mean dose and quantification of error for Lopez B; Mahvash A; Lam MGEH; Kappadath SC Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600 [TBL] [Abstract][Full Text] [Related]
25. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy. Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323 [TBL] [Abstract][Full Text] [Related]
26. SPECT and CT misregistration reduction in [ Lu Z; Chen G; Jiang H; Sun J; Lin KH; Mok GSP Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2319-2330. PubMed ID: 36877236 [TBL] [Abstract][Full Text] [Related]
27. Lung shunt fraction calculation using Georgiou MF; Kuker RA; Studenski MT; Ahlman PP; Witte M; Portelance L EJNMMI Res; 2021 Sep; 11(1):96. PubMed ID: 34585259 [TBL] [Abstract][Full Text] [Related]
28. 90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival. Xing M; Lahti S; Kokabi N; Schuster DM; Camacho JC; Kim HS Clin Nucl Med; 2016 Jan; 41(1):21-7. PubMed ID: 26222534 [TBL] [Abstract][Full Text] [Related]
29. Monte Carlo simulation of PET and SPECT imaging of 90Y. Takahashi A; Himuro K; Yamashita Y; Komiya I; Baba S; Sasaki M Med Phys; 2015 Apr; 42(4):1926-35. PubMed ID: 25832083 [TBL] [Abstract][Full Text] [Related]
30. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126 [TBL] [Abstract][Full Text] [Related]
31. 90Y PET-based dosimetry after selective internal radiotherapy treatments. D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156 [TBL] [Abstract][Full Text] [Related]
32. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres. Elschot M; Nijsen JF; Lam MG; Smits ML; Prince JF; Viergever MA; van den Bosch MA; Zonnenberg BA; de Jong HW Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055 [TBL] [Abstract][Full Text] [Related]
33. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. Kao YH; Steinberg JD; Tay YS; Lim GK; Yan J; Townsend DW; Takano A; Burgmans MC; Irani FG; Teo TK; Yeow TN; Gogna A; Lo RH; Tay KH; Tan BS; Chow PKh; Satchithanantham S; Tan AE; Ng DC; Goh AS EJNMMI Res; 2013 Jul; 3(1):56. PubMed ID: 23883566 [TBL] [Abstract][Full Text] [Related]
34. Low-dose 90Y PET/CT imaging optimized for lesion detectability and quantitative accuracy: a phantom study to assess the feasibility of pretherapy imaging to plan the therapeutic dose. Khazaee M; Kamali-Asl A; Geramifar P; Rahmim A Nucl Med Commun; 2017 Nov; 38(11):985-997. PubMed ID: 28902765 [TBL] [Abstract][Full Text] [Related]
35. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization. Ezponda A; Rodríguez-Fraile M; Morales M; Vivas I; De La Torre M; Sangro B; Bilbao JI Cardiovasc Intervent Radiol; 2020 Jul; 43(7):987-995. PubMed ID: 31848672 [TBL] [Abstract][Full Text] [Related]
36. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing Noipinit N; Sukprakun C; Siricharoen P; Khamwan K Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421 [TBL] [Abstract][Full Text] [Related]